X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA ORCHID PHARMA LTD PLETHICO PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x -1.1 -0.6 - View Chart
P/BV x 0.0 0.4 3.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ORCHID PHARMA LTD
Sep-13
PLETHICO PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs395194 203.6%   
Low Rs3135 89.4%   
Sales per share (Unadj.) Rs604.4276.5 218.6%  
Earnings per share (Unadj.) Rs32.5-79.2 -41.0%  
Cash flow per share (Unadj.) Rs51.3-43.5 -118.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.653.9 878.0%  
Shares outstanding (eoy) m34.0870.45 48.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.40.4 85.1%   
Avg P/E ratio x6.6-1.4 -453.9%  
P/CF ratio (eoy) x4.2-2.6 -157.6%  
Price / Book Value ratio x0.52.1 21.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2628,067 90.0%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m1,5962,527 63.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m20,59819,477 105.8%  
Other income Rs m386407 94.9%   
Total revenues Rs m20,98419,884 105.5%   
Gross profit Rs m2,8181,103 255.5%  
Depreciation Rs m6422,519 25.5%   
Interest Rs m1,5935,227 30.5%   
Profit before tax Rs m969-6,236 -15.5%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-138-125 110.5%   
Profit after tax Rs m1,107-5,580 -19.8%  
Gross profit margin %13.75.7 241.6%  
Effective tax rate %-14.32.0 -711.7%   
Net profit margin %5.4-28.7 -18.8%  
BALANCE SHEET DATA
Current assets Rs m18,87711,014 171.4%   
Current liabilities Rs m11,89632,060 37.1%   
Net working cap to sales %33.9-108.1 -31.4%  
Current ratio x1.60.3 461.9%  
Inventory Days Days3695 37.9%  
Debtors Days Days19834 589.5%  
Net fixed assets Rs m9,86129,440 33.5%   
Share capital Rs m341705 48.4%   
"Free" reserves Rs m12,3312,043 603.7%   
Net worth Rs m16,1393,800 424.7%   
Long term debt Rs m4,7069,018 52.2%   
Total assets Rs m33,14646,510 71.3%  
Interest coverage x1.6-0.2 -832.6%   
Debt to equity ratio x0.32.4 12.3%  
Sales to assets ratio x0.60.4 148.4%   
Return on assets %8.1-0.8 -1,071.8%  
Return on equity %6.9-146.9 -4.7%  
Return on capital %12.3-3.7 -329.1%  
Exports to sales %21.437.9 56.4%   
Imports to sales %15.222.6 67.3%   
Exports (fob) Rs m4,4027,378 59.7%   
Imports (cif) Rs m3,1364,406 71.2%   
Fx inflow Rs m4,4027,513 58.6%   
Fx outflow Rs m3,1845,649 56.4%   
Net fx Rs m1,2191,865 65.4%   
CASH FLOW
From Operations Rs m2,4371,682 144.9%  
From Investments Rs m-6,265-9,860 63.5%  
From Financial Activity Rs m2,4906,644 37.5%  
Net Cashflow Rs m-1,337-1,535 87.1%  

Share Holding

Indian Promoters % 82.7 32.3 256.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 4.6 93.5%  
FIIs % 5.5 3.3 166.7%  
ADR/GDR % 0.0 4.6 -  
Free float % 7.5 55.3 13.6%  
Shareholders   10,665 84,811 12.6%  
Pledged promoter(s) holding % 85.7 54.9 156.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS